Has your patient been treated for cancer?

8 July 2019


Is your patient one of the over 330 patients in this region, enrolled in the ESCAPI Study? If so, you would have received a letter informing you that they are enrolled at the end of 2018, and another letter this year to let you know the study is nearing its end. We are keen to hear from the GPs who have patient/s enrolled in the study. All that is required is one interview, which can be face to face or on the phone, at a time convenient to you. You will be remunerated $100 for the interview.  

The ESCAPI Study is a NHMRC Trial that aims to improve support of patients receiving chemotherapy, and establish a pathway that enhances communication and follow up. Your perspective is essential to ensure recommendations include the GP experience is captured in the study findings.

Please contact Dr Chantale Boustany (Research Manager) on chantale.boustany@sydney.edu.au  or on (02) 8627 0405 for more information and/or to organise an interview.